Pricing Log in Create free account

CalciMedica Inc. (CALC) vs Moleculin Biotech, Inc. (MBRX)

CalciMedica Inc. and Moleculin Biotech, Inc. are both Biotechnology companies. CalciMedica Inc. and Moleculin Biotech, Inc. are of similar size ($7.6M and $7.4M). CalciMedica Inc. has negative trailing earnings, so its P/E is not meaningful; Moleculin Biotech, Inc. trades at 0.0×. Across the 11 metrics below, CalciMedica Inc. leads on 7 and Moleculin Biotech, Inc. on 4.

Valuation

Metric CALC MBRX Biotechnology median
P/E n/m 0.03 8.50
P/S n/m n/m 9.71
P/B 0.66 0.14 2.13
Price to free cash flow n/m n/m 20.82
EV/EBITDA 0.17 0.19 0.64
EV/Sales n/m n/m 9.21
Earnings yield (630.84%) 4,008.00% (33.15%)
Free cash flow yield (521.48%) (1,600.09%) (25.50%)

Profitability

Metric CALC MBRX Biotechnology median
Gross margin 0.00% 0.00% 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity (365.70%) (1,471.05%) (56.36%)
Return on assets (110.10%) (152.41%) (48.04%)
Return on invested capital 0.00% (417.27%) 0.00%

Growth

Metric CALC MBRX Biotechnology median
Revenue growth (TTM) — — 6.02%
EPS growth (last fiscal year) (61.48%) 82.01% 30.26%
Revenue growth, 5-year CAGR — — 9.41%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CALC MBRX Biotechnology median
Debt to equity 1.67 0.00 0.00
Current ratio 5.58 0.94 4.72
Net debt to EBITDA 0.14 0.35 0.96

Dividend

Metric CALC MBRX Biotechnology median
Dividend yield — — 0.09%
Payout ratio — — —

Size

Metric CALC MBRX Biotechnology median
Market cap 7.38m 7.55m 135.18m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack